| Authors: |
Nicholson TB; 1] Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA [2] Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Su H; 1] Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA [2] Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Hevi S; 1] Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA [2] Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Wang J; Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Bajko J; Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Li M; Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Valdez R; Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Loureiro J; Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Cheng X; Department of Biochemistry, Emory University, Atlanta, GA 30322, USA., Li E; Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Kinzel B; Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Novartis Pharma AG Forum 1 Novartis Campus CH-4056, Basel, Switzerland., Labow M; Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Chen T; 1] Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA [2] Epigenetics Program, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA [3] Current address: Department of Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX 78957, USA. |
